Aspergillosis News and Research

RSS

Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

Study explores immunoregulatory nanomedicines for respiratory infections, highlighting their potential in enhancing treatment outcomes and vaccine efficacy.

7 Dec 2023

Fighting invisible foes: How cryptic fungal pathogens threaten human health and food security

The research paper in PLOS Pathogens delves into the challenges of diagnosing and treating cryptic fungal pathogens, which are difficult to distinguish from common fungi but equally dangerous. The study calls for more accurate diagnostic methods and a better understanding of how these fungi interact with the human immune system and microbiome for effective treatment and prevention.

25 Oct 2023

Color of the phlegm can indicate degree of lung inflammation in patients with bronchiectasis

The color of the phlegm from patients with the lung disease bronchiectasis can indicate the degree of inflammation in their lungs and predict their future outcomes, according to new research presented at the European Respiratory Society International Congress in Milan, Italy.

11 Sep 2023

Understanding the mechanisms behind rising antifungal drug resistance

In a recent study, researchers addressed the issue of the rise of antifungal drugs-resistant infections and the advent of multidrug-resistant fungal pathogens.

19 Jul 2023

New drug shows synergistic effect with antifungals in killing drug-resistant fungi

A study conducted at the University of São Paulo (USP) in Brazil shows that brilacidin, a new drug tested for treatment of diseases ranging from bacterial skin infections to COVID-19, can kill drug-resistant strains of fungi when combined with two classes of antifungals available on the market.

10 Jul 2023

How did the COVID-19 pandemic impact the fungal infection hospitalization rates?

Researchers examined hospitalizations for fungal infections during the coronavirus disease 2019.

9 Jun 2023

Analyzing impact of phospholipase D on the host immune response to A. fumigatus infection

Announcing a new article publication for Zoonoses journal. Aspergillus fumigatus infection in the lungs is accompanied by the recruitment of innate immune cells, phagocytosis, and the release of inflammatory factors.

11 May 2023

How antiviral host responses create a lung environment susceptible to bacterial and fungal infections

A recent study discussed coinfections in the lungs and how viral infections create a favorable environment for bacteria and fungi.

8 May 2023

New insights into deadly fungal invasion in people with compromised immune systems

Fungi such as Aspergillus are so common in our surroundings that we breathe in hundreds to thousands of spores every day.

12 Jan 2023

Shared genetic effects between the autoimmune disease systemic lupus erythematosus and the clinical consequences of COVID-19

Researchers identified a genetic association signal, via genome-wide association studies, between severe COVID-19 with systemic lupus erythematosus, an autoimmune disease.

7 Nov 2022

An unprecedented list of health-threatening fungi released by the WHO

The WHO fungal priority pathogens list ranks pathogens that pose a serious risk of morbidity and mortality in humans.

27 Oct 2022

Study presents rare cases of COVID-19-associated pulmonary aspergillosis

Researchers presented a case series of patients with coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA). The goal of the study was to inform clinicians and healthcare workers of this serious COVID-19-related complication.

14 Oct 2022

Exploring remdesivir resistance in COVID-19-infected transplant recipients

In a new study, researchers assessed the remdesivir resistance developed in coronavirus disease 2019 (COVID-19)-infected transplant recipients.

29 Sep 2022

Novel antifungal medications urgently needed to control COVID-19-associated fungal infections

Every day we inhale thousands of potentially pathogenic fungal spores, but our immune system simply eliminates them.

9 Sep 2022

High prevalence of fungal secondary infections among COVID-19 patients

Researchers analyze literature to explore the frequency of secondary fungal infections among COVID-19 patients.

2 Aug 2022

Scientists explore COVID-19-associated pulmonary aspergillosis

Researchers computationally investigated the causes of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA).

25 Jul 2022

Drug-resistant mold found to be spreading and infecting susceptible people's lungs

A new study led by Imperial College London finds that drug-resistant mold is spreading from the environment and infecting susceptible people's lungs.

25 Apr 2022

New aspergillosis infection model can help better observe the growth of fungus

A chip-based infection model developed by researchers in Jena, Germany, enables live microscopic observation of damage to lung tissue caused by the invasive fungal infection aspergillosis.

13 Apr 2022

Compounds used to fight fungal diseases in plants may be driving antimicrobial resistance

New research from the University of Georgia has shown, for the first time, that compounds used to fight fungal diseases in plants are causing resistance to antifungal medications used to treat people.

8 Feb 2022

Scientists develop new diagnostic procedure for pulmonary aspergillosis

Scientists have developed a pioneering new procedure that will help diagnose a potentially lethal fungal lung disease with greater speed and accuracy, and with less distress to the patient.

23 Mar 2021